MARKET

TMDX

TMDX

Transmedics Group
NASDAQ
123.48
+2.17
+1.79%
After Hours: 122.88 -0.6 -0.49% 19:54 03/13 EDT
OPEN
122.00
PREV CLOSE
121.31
HIGH
124.79
LOW
121.16
VOLUME
505.44K
TURNOVER
--
52 WEEK HIGH
156.00
52 WEEK LOW
62.23
MARKET CAP
4.24B
P/E (TTM)
26.31
1D
5D
1M
3M
1Y
5Y
1D
TransMedics Group Inc. Files Initial Beneficial Ownership Statement for Matthew S. Forsyth, Senior Vice President, General Counsel and Secretary
Reuters · 11h ago
Reiterating Buy on TransMedics: Defensible OCS Leadership and Organ Management Expansion Drive Sustained Growth Outlook
TipRanks · 23h ago
TransMedics: Early 2026 DCD and Liver Transplant Momentum Supports Upside and Maintained Buy Rating
TipRanks · 3d ago
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade)
Seeking Alpha · 4d ago
TransMedics: Numb Reaction To Extraordinary Fundamentals
Seeking Alpha · 4d ago
TransMedics Group Price Target Raised to $130.00/Share From $115.00 by Stifel
Dow Jones · 4d ago
TransMedics Group Is Maintained at Hold by Stifel
Dow Jones · 4d ago
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $130
Benzinga · 4d ago
More
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Webull offers TransMedics Group Inc stock information, including NASDAQ: TMDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TMDX stock methods without spending real money on the virtual paper trading platform.